Cost savings from integrative medicine via pain reduction in hospitalized patients

May 10, 2018

New Rochelle, NY, May 10, 2018-- Researchers at Allina Health (Minneapolis, MN) conducted a large NIH-funded observational study to examine pain treatment outcomes of integrative medicine in hospitalized patients. What they found was that when integrative interventions lowered pain there was an associated cost saving according to a recent article in JACM (The Journal of Alternative and Complementary Medicine). JACM is a peer-reviewed journal from Mary Ann Liebert, Inc., publishers dedicated to examining paradigm, practice, and policy advancing integrative health. The article is available free on JACM website.

In "Cost Savings from Reducing Pain Through the Delivery of Integrative Medicine Program to Hospitalized Patients," lead investigator Jeffery Dusek, PhD (then with Integrative Health Research Center, Penny George Institute for Health and Healing, Allina Health and now with the Kripalu Center for Yoga and Health) and a team that included Michael Finch, PhD and David Watson, PhD (Children's Minnesota Research Institute) examined EPIC-based electronic health record for 2730 hospitalized patients during the study period. Through a methodology that associated reduction in pain with reduction in hospital costs, the researchers determined that pain reductions from integrative medicine interventions were associated with a cost savings approaching $1,000 per hospital admission for those receiving integrative medicine.

"The results indicate that when integrative medicine interventions reduce patients' perception of pain in the acute care setting, there is a corresponding decrease in the total cost of the patients' care," states Jeffery Dusek, PhD, adding: "While the amount of savings are substantial, future studies are needed to optimize the delivery of the integrative medicine interventions in order to maximize the cost savings."

"Credit NIH National Center for Complementary and Integrative Health for the investment in this critically important - yet still rare - exploration of cost outcomes from integrative practices," comments JACM Editor-in-Chief John Weeks,, Seattle, WA. "The value proposition for these integrative practices - both in cost and patient care - may be even stronger if one considers the potential - not measured here - that the integrative medicine also reduced use of opioids, those limiting attendant societal costs of those agents."
Research reported in this publication was supported, in part, by a grant from the National Center for Complementary and Alternative Medicine (NCCAM) now the National Center for Complementary and Integrative Health (NCCIH) of the National Institutes of Health to JAD (AT006518).

About the Journal

JACM (The Journal of Alternative and Complementary Medicine) is a monthly peer-reviewed journal published online with open access options and in print that is dedicated to research on paradigm, practice, and policy advancing integrative health. Led by John Weeks (, the co-founder and past Executive Director of the Academic Collaborative for Integrative Health, JACM publishes human clinical trials, observational studies, systematic reviews and commentary intended to help healthcare professionals, delivery organization leaders, policy-makers and scientists evaluate and integrate therapies into patient care protocols, payment strategies and appropriate protocols. Complete tables of content and a sample issue may be viewed on the JACM website.

About the Publisher

Mary Ann Liebert, Inc., publishers is a privately held, fully integrated media company known for establishing authoritative peer-reviewed journals in many promising areas of science and biomedical research, including Alternative and Complementary Therapies, Medical Acupuncture, and Journal of Medicinal Food. Its biotechnology trade magazine, GEN (Genetic Engineering & Biotechnology News), was the first in its field and is today the industry's most widely read publication worldwide. A complete list of the firm's 80 journals, books, and newsmagazines is available on the Mary Ann Liebert, Inc., publishers website.

Mary Ann Liebert, Inc./Genetic Engineering News

Related Pain Articles from Brightsurf:

Pain researchers get a common language to describe pain
Pain researchers around the world have agreed to classify pain in the mouth, jaw and face according to the same system.

It's not just a pain in the head -- facial pain can be a symptom of headaches too
A new study finds that up to 10% of people with headaches also have facial pain.

New opioid speeds up recovery without increasing pain sensitivity or risk of chronic pain
A new type of non-addictive opioid developed by researchers at Tulane University and the Southeast Louisiana Veterans Health Care System accelerates recovery time from pain compared to morphine without increasing pain sensitivity, according to a new study published in the Journal of Neuroinflammation.

The insular cortex processes pain and drives learning from pain
Neuroscientists at EPFL have discovered an area of the brain, the insular cortex, that processes painful experiences and thereby drives learning from aversive events.

Pain, pain go away: new tools improve students' experience of school-based vaccines
Researchers at the University of Toronto and The Hospital for Sick Children (SickKids) have teamed up with educators, public health practitioners and grade seven students in Ontario to develop and implement a new approach to delivering school-based vaccines that improves student experience.

Pain sensitization increases risk of persistent knee pain
Becoming more sensitive to pain, or pain sensitization, is an important risk factor for developing persistent knee pain in osteoarthritis (OA), according to a new study by researchers from the Université de Montréal (UdeM) School of Rehabilitation and Hôpital Maisonneuve Rosemont Research Centre (CRHMR) in collaboration with researchers at Boston University School of Medicine (BUSM).

Becoming more sensitive to pain increases the risk of knee pain not going away
A new study by researchers in Montreal and Boston looks at the role that pain plays in osteoarthritis, a disease that affects over 300 million adults worldwide.

Pain disruption therapy treats source of chronic back pain
People with treatment-resistant back pain may get significant and lasting relief with dorsal root ganglion (DRG) stimulation therapy, an innovative treatment that short-circuits pain, suggests a study presented at the ANESTHESIOLOGY® 2018 annual meeting.

Sugar pills relieve pain for chronic pain patients
Someday doctors may prescribe sugar pills for certain chronic pain patients based on their brain anatomy and psychology.

Peripheral nerve block provides some with long-lasting pain relief for severe facial pain
A new study has shown that use of peripheral nerve blocks in the treatment of Trigeminal Neuralgia (TGN) may produce long-term pain relief.

Read More: Pain News and Pain Current Events is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to